TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway

被引：0

作者：

Liqiang Shi ^{[1
]}

Yajie Zhang ^{[1
]}

Cong Yang ^{[2
]}

Yaxin Wang ^{[1
]}

Yichao Han ^{[1
]}

Chuanyin Li ^{[3
]}

Yun Yang ^{[4
]}

Dong Dong ^{[1
]}

Mingyuan Du ^{[1
]}

Hecheng Li ^{[1
]}

机构：

[1] Ruijin Hospital,Department of Thoracic Surgery

[2] Shanghai Jiao Tong University School of Medicine,Cancer Center, School of Medicine, Shanghai Tenth People’s Hospital

[3] Tongji University,Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affi

[4] Zhejiang University School of Medicine,Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Sciences, Hangzhou Institute for Advanced Study

[5] University of Chinese Academy of Sciences,undefined

来源：

Journal of Cancer Research and Clinical Oncology | / 151卷 / 4期

关键词：

TROAP; Esophageal squamous cell carcinoma; Malignant phenotype; PI3K/AKT;

D O I：

10.1007/s00432-025-06200-2

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
Jia, Yang
Xiao, Zhaohua
Xin Gongsun
Xin, Zhongwei
Shang, Bin
Chen, Gang
Wang, Zhou
Jiang, Wenpeng
ONCOTARGETS AND THERAPY, 2018, 11 : 4221 - 4232
[2] YBX1 promotes tumor progression via the PI3K/AKT signaling pathway in laryngeal squamous cell carcinoma
Zhao, Jing
Zhang, Pu
Wang, Xin
TRANSLATIONAL CANCER RESEARCH, 2021, 10 (11) : 4859 - 4869
[3] The Comprehensive Analysis of PI3K/AKT Pathway and miRNAs in Esophageal Squamous Cell Carcinoma
Akagi, Ichiro
Matsutani, Takeshi
Ishibashi, Osamu
Makino, Hiroshi
Yoshida, Hiroshi
Nomura, Tsutomu
Hagiwara, Nobutoshi
Maruyama, Hiroshi
Yokoyama, Tadashi
Hirakata, Atsushi
Ueda, Junji
Miyashita, Masao
Uchida, Eiji
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S698 - S698
[4] Knockdown of Metadherin suppressed the progression of oral squamous cell carcinoma via PI3K/AKT signaling pathway
Ding, Z. Y.
Dong, G.
Yin, G.
Yu, L. L.
Li, W. X.
Ding, B.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01): : 303 - 309
[5] ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
Ni, Sheng
Wei, Qian
Yang, Li
ONCOTARGETS AND THERAPY, 2020, 13 : 12409 - 12419
[6] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
Yu, Xinxin
Zheng, Yan
Zhu, Xuchao
Gao, Xiaomei
Wang, Chaoqun
Sheng, Yuanyuan
Cheng, Wei
Qin, Lunxiu
Ren, Ning
Jia, Huliang
Dong, Qiongzhu
ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
[7] DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway
Guo, Wenbo
Qu, Yun
Yu, Yang
Li, Xueming
Liang, Zhuang
Wang, Zhaoqi
Hu, Tenglong
Zhou, Shan
AGING-US, 2024, 16 (10): : 9204 - 9215
[8] MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway
Qiao Guanen
Shi Junjie
Wu Baolin
Wang Chaoyang
Yang Yajuan
Li Jing
Li Junpeng
Ning Gaili
Wang Zhongping
Wang Jun
BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 : 350 - 361
[9] CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling
Huang, Yongsheng
Lin, Lehang
Shen, Zhuojian
Li, Yu
Cao, Haotian
Peng, Li
Qiu, Yuntan
Cheng, Xu
Meng, Meng
Lu, Daning
Yin, Dong
AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (10): : 3328 - +
[10] Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway
Qiao, Zhongshi
Dai, Chengcheng
Wang, Zhiqian
Wang, Zifan
Wang, Zheng
Zhang, Tongsong
Niu, Wenjing
Ma, Xuezhen
THORACIC CANCER, 2022, 13 (08) : 1117 - 1125

← 1 2 3 4 5 →